|
Originally published In Press as doi:10.1074/jbc.M111365200 on December 13, 2001
J. Biol. Chem., Vol. 277, Issue 9, 7420-7429, March 1, 2002
A Critical Role for Pin2/TRF1 in ATM-dependent
Regulation
INHIBITION OF Pin2/TRF1 FUNCTION COMPLEMENTS TELOMERE
SHORTENING, RADIOSENSITIVITY, AND THE G2/M CHECKPOINT
DEFECT OF ATAXIA-TELANGIECTASIA CELLS*
Shuji
Kishi and
Kun Ping
Lu§
From the Cancer Biology Program, Division of Hematology/Oncology,
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard
Medical School, Boston, Massachusetts 02215
Received for publication, November 28, 2001
 |
ABSTRACT |
Cells derived from patients with the human
genetic disorder ataxia-telangiectasia (A-T) display many
abnormalities, including telomere shortening, premature senescence, and
defects in the activation of S phase and G2/M
checkpoints in response to double-strand DNA breaks induced by ionizing
radiation. We have previously demonstrated that one of the ATM
substrates is Pin2/TRF1, a telomeric protein that binds the potent
telomerase inhibitor PinX1, negatively regulates telomere elongation,
and specifically affects mitotic progression. Following DNA damage, ATM
phosphorylates Pin2/TRF1 and suppresses its ability to induce abortive
mitosis and apoptosis (Kishi, S., Zhou, X. Z., Nakamura, N., Ziv,
Y., Khoo, C., Hill, D. E., Shiloh, Y., and Lu, K. P. (2001)
J. Biol. Chem. 276, 29282-29291). However, the
functional importance of Pin2/TRF1 in mediating
ATM-dependent regulation remains to be established. To
address this question, we directly inhibited the function of endogenous
Pin2/TRF1 in A-T cells by stable expression of two different
dominant-negative Pin2/TRF1 mutants and then examined their effects on
telomere length and DNA damage response. Both the Pin2/TRF1 mutants
increased telomere length in A-T cells, as shown in other cells.
Surprisingly, both the Pin2/TRF1 mutants reduced radiosensitivity and
complemented the G2/M checkpoint defect without inhibiting
Cdc2 activity in A-T cells. In contrast, neither of the Pin2/TRF1
mutants corrected the S phase checkpoint defect in the same cells.
These results indicate that inhibition of Pin2/TRF1 in A-T cells
is able to bypass the requirement for ATM in specifically restoring
telomere shortening, the G2/M checkpoint defect, and
radiosensitivity and demonstrate a critical role for Pin2/TRF1 in the
ATM-dependent regulation of telomeres and DNA damage response.
 |
INTRODUCTION |
Mutations in the
ATM1 gene are
responsible for the genetic disease ataxia telangiectasia (A-T) (1).
Cells derived from A-T patients display many abnormalities, including
telomere shortening, premature senescence, and hypersensitivity to
ionizing radiation (2, 3). Exposure of normal mammalian cells to
ionizing radiation leads to a delay in progression of the cell from
G1 to S phase, inhibition of DNA synthesis, and a delay in
progression from G2 phase into mitosis (4, 5). Similar
mechanisms are also presented in yeast cells (6, 7). These cell cycle
checkpoints allow cells to repair damaged DNA and to maintain genomic
stability (3, 8). However, A-T cells are defective in activating
checkpoints at the G1/S, during S phase, and at the
G2/M in response to ionizing radiation exposure (2). ATM is
a protein kinase that is activated by ionizing DNA damage and is
critical for genome stability, telomere maintenance, and induction of
cell cycle checkpoints (2, 3). ATM has been shown to phosphorylate and
regulate many key regulators, including p53, -adaptin, c-Abl,
Chk1-2, Brca1, and Nijmegen breakage syndrome protein (9-19). For
example, ATM phosphorylates p53 and thereby increases transcription of
the Cdk inhibitor p21 and the Cdc2 sequester 14-3-3 . Furthermore,
ATM also phosphorylates Chks, which eventually leads to inhibition of
Cdc2 activation. These multiple and redundant pathways have been shown
to be involved in cell cycle checkpoint regulation (2, 3).
An increasing body of evidence supports an important role for ATM in
regulating telomere metabolism. Cells derived from humans and mice with
a defective ATM gene show prominent defects related to
telomere dysfunction (1, 20-23). Both primary and transformed A-T
cells have been found to have unusually short telomeres and chromosome
end-to-end associations, and primary A-T cells show premature
aging/senescence phenotype (24-29). Furthermore, expression of a
dominant-negative ATM fragment in normal cells results in a decrease in
average telomere repeat length (29, 30). Moreover, ATM has been
implicated in regulation of chromosome end associations and telomere
nuclear matrix interactions (31). In yeast, deletion of ATM homologous
genes TEL1 and MEC1 also leads to accelerated telomere shortening, premature aging, and the G2/M
checkpoint defect (32-35). Interestingly, yeast TEL1 partially
substitutes for human ATM in suppressing ionizing radiation-induced
apoptosis and telomere shortening in A-T cells (36), and overexpression of telomerase elongates telomeres and extends the life span of A-T
cells (37). These results indicate that ATM plays a crucial role in
regulation of telomere maintenance and the G2/M checkpoint. However, overexpression of telomerase does not rescue radiosensitivity, telomere fusion, or cell cycle checkpoint defects in A-T cells (37). In
addition, deletion of both TEL1 and MEC1 in yeast does not affect
telomerase activity and still allows telomerase to act when the
telomere structure is disrupted (38). These results indicate that the
primary function of ATM in telomere maintenance is not to regulate
telomerase activity but rather to act on telomeres or telomere proteins
(38).
Our previous studies indicate that one of the ATM substrates in the
regulation of telomeres and mitotic progression is the telomere protein
Pin2/TRF1 (39). Pin2/TRF1 was originally identified by its ability to
bind telomeric DNA repeats (TRF1) (40) or to bind the mitotic kinase
NIMA and suppress its ability to induce mitotic catastrophe (Pin2) (41,
42). Pin2 is identical to TRF1 with the exception of a 20-amino
acid internal deletion but is 5-10-fold more abundant than TRF1 in the
cell (43); they are likely generated from the same gene
PIN2/TRF1 (44). For clarity, we will use Pin2 for the
20-amino acid deletion isoform and TRF1 for the 20-amino
acid-containing isoform, as they were originally identified (40, 41,
43), and use Pin2/TRF1 for endogenous proteins. Overexpression of
Pin2/TRF1 accelerates telomere loss, whereas dominant-negative
Pin2/TRF1 increases telomere length, indicating that Pin2/TRF1 is a
negative regulator of telomere elongation (45). Furthermore, Pin2/TRF1
interacts with tankyrase and Tin2, which modulate telomere metabolism
(46, 47). Although Pin2/TRF1, tankyrase, and Tin2 do not directly
inhibit telomerase activity (45-47), we have recently demonstrated
that Pin2/TRF1 binds a potent telomerase inhibitor, PinX1, which
directly inhibits telomerase, shortens telomeres, and induces cells
into crisis (48). These results indicate that Pin2/TRF1 plays a key
role in the regulation of telomere maintenance.
In addition, we have shown that both the protein level and subcellular
localization of Pin2/TRF1 are tightly regulated during the cell cycle.
Pin2/TRF1 levels are increased in the G2/M (43). Furthermore, Pin2/TRF1 specifically localizes to the mitotic spindle during mitosis and affects microtubule assembly (49, 50). Moreover,
overexpression of Pin2/TRF1 induces abortive mitosis and apoptosis in
cells containing short telomeres but not in those containing long
telomeres (51). These results indicate that Pin2/TRF1 also plays an
important role in mitotic progression. This is consistent with other
studies linking telomere regulation to mitotic progression. For
example, elimination or mutation of telomeres causes a Rad9p-mediated
cell cycle arrest in G2 in budding yeast (52), triggers
abortive mitosis and apoptosis in Drosophila (53), or causes
a severe delay or block in anaphase, displaying an anaphase bridge in
Tetrahymena (54).
Interestingly, we have also demonstrated that Pin2/TRF1 binds with ATM
in vitro and in vivo (39). Furthermore, ATM
activated by DNA damage directly phosphorylates Pin2/TRF1
preferentially on serine 219 and also suppresses its ability to induce
abortive mitosis and apoptosis (39). Moreover, point mutations in
Pin2/TRF1 mimicking ATM phosphorylation completely abolished its
ability to induce apoptosis, whereas replacing the ATM phosphorylation site with a nonphosphorylatable residue rendered Pin2 resistant to
suppression by ATM (39). In addition, overexpression of Pin2/TRF1 results in phenotypes similar to those of ATM mutations, including accelerated telomere shortening (45-48), abortive mitosis, and apoptosis (51). These results suggest that ATM may inhibit the function of Pin2/TRF1 during DNA damage response. However, the physiological importance of Pin2/TRF1 in mediating
ATM-dependent regulation remains to be determined.
To address this question, we here inhibited the function of endogenous
Pin2/TRF1 in A-T cells by stable expression of two different
dominant-negative Pin2/TRF1 mutants. Both the mutants increased
telomere length in A-T cells. More importantly, both the mutants
reduced radiosensitivity and restored the G2/M checkpoint defect without inhibiting Cdc2 activation in A-T cells. In contrast, neither of the mutants affected the S phase checkpoint defect in same
cells. These results indicate that inhibition of Pin2/TRF1 can
specifically suppress telomere shortening, the G2/M
checkpoint defect, and radiosensitivity in A-T cells and demonstrate a
critical role for Pin2/TRF1 in mediating some aspects of phenotypes
associated with ATM mutations.
 |
EXPERIMENTAL PROCEDURES |
Stable Expression of ATM or Dominant-negative Pin2/TRF1 Mutants
in A-T Cells--
For stable expression of ATM, pEBS7 vector encoding
full-length ATM tagged with FLAG or the control vector were stably
transfected into parental A-T22IJE-T cells as described (39, 55). After selection with hygromycin B (200 µg/ml) and limited dilution, multiple clones were isolated and checked for ATM expression by immunoblotting analysis with anti-ATM antibody (Ab-3) and anti-FLAG antibody (M5). For stable expression of Pin2 mutants, cDNA
encoding Pin2-(1-372) and Pin2-(1-316) were cloned into the pEGFP-C1
vector and stably transfected into A-T22IJE-T cells. After selection with G418 (1 mg/ml), GFP-expressed cells were picked up under a
fluorescence microscope. Multiple stable clones were obtained with
similar properties. To detect expression of GFP fusion proteins in the
cells, trypsinized cells were resuspended in Dulbecco's modified
Eagle's medium supplemented with 10% fetal bovine serum, washed in
phosphate-buffered saline (PBS), and then immediately analyzed by flow
cytometry (BD PharMingen) for detection of the GFP fluorescence
intensity of individual cells with nontransfected cells as a negative
control or by immunoblotting analysis with anti-GFP antibodies.
Analysis of Telomere Restriction Fragment Length--
Telomere
restriction fragment length was determined as described previously
(48). Briefly, genomic DNA was isolated and digested with restriction
enzymes HinfI and RsaI (New England Biolabs),
separated on 0.7% agarose gels (2 µg of DNA per lane). The gels were
dried, but not completely, and then hybridized in-gel with a 500-bp
telomeric DNA fragment labeled with [ -32P]dCTP by
standard protocols, followed by autoradiography.
Telomere FISH Analysis--
Telomere FISH was carried out as
described previously (39). Briefly, cells grown on coverslips were
washed once in Tris-buffered saline (TBS) and incubated in 3.7%
formaldehyde in TBS for 10 min at room temperature. These prepared
cells were then denatured in a hybridization mixture containing 70%
deionized formamide, 20 mM Tris pH 7.0, 1% bovine serum
albumin, and 10 nM Cy3-labeled PNA telomere repeat probe
(PerSeptive Biosystems, Framingham, MA) for 10 min at
80 °C. A hybridization was performed for 12 h at room
temperature. Finally, DNA was counterstained with 0.5 mg/ml DAPI, and
preparations were mounted in antifade solution (Vectashield, Vector
Labs). Samples were observed using a fluorescence microscope, and
digital images were recorded with a CCD camera. Quantitative
fluorescence intensity of individual cells was evaluated by NIH Image software.
Senescence-associated -Galactosidase Activity Assay--
To
stain for senescence-associated -galactosidase (SA- -Gal), cells
grown in dishes or on coverslips were washed with PBS and fixed in
0.5% glutaraldehyde. The cells were then incubated with staining
solution (1 mg/ml 5-bromo-4-chloro-3-indolyl-galactoside, 5 mM potassium ferrocyanide, 5 mM potassium
ferricyanide, and 1 mM MgCl2 in PBS at pH 6.0)
for ~12 h at 37 °C, as reported previously (48, 56). Cells were
rinsed in PBS, and the staining and cell morphology were determined
under a microscope.
Colony Formation Assay--
Experiments were carried out
according to previously published protocols (55, 57). Briefly, 50%
confluent monolayer cultures at logarithmic stage were irradiated, and
after 14-21 days the resultant colonies were fixed and stained with
2% crystal violet in 50% ethanol and counted under a dissecting microscope.
Cell Cycle Analysis--
For cell cycle analysis, cells were
harvested by trypsinization, resuspended in Dulbecco's modified
Eagle's medium supplemented with 10% serum, washed in PBS, and then
fixed in 70% ethanol. After washing cells once with PBS containing 1%
bovine serum albumin, DNA was stained with propidium iodide (10 µg/ml) containing 250 µg/ml of ribonuclease A, followed by flow
cytometry analysis (BD PharMingen) as described (42, 51). DNA synthesis
was assayed by incubation with 10 µM BrdUrd for 60 min,
and incorporation of BrdUrd into cells was determined by staining cells
with PE-conjugated anti-BrdUrd monoclonal antibody, followed by flow
cytometry according to the manufacturer's protocol (BD PharMingen) as
described (48). Tyr-15 phosphorylation status and histone H1 kinase
activity of Cdc2 were assayed as described previously (42, 58).
 |
RESULTS |
Stable Expression of Two Different Dominant-negative
Pin2/TRF1 Mutants, Pin2-(1-372) and Pin2-(1-316), or ATM in
A-T Cells--
Overexpression of Pin2/TRF1 induces telomere
shortening, abortive mitosis, and apoptosis (45, 51). Furthermore, ATM
phosphorylates Pin2/TRF1 and suppresses its ability to induce abortive
mitosis and apoptosis (39). Interestingly, A-T cells contain shortened telomeres and enter abortive mitosis and apoptosis upon ionizing radiation (25-28, 30, 55, 59). These results suggest that one of the
major functions of ATM activation following DNA damage may be to
inhibit Pin2/TRF1 function. If this is the case, direct inhibition of
endogenous Pin2/TRF1 function in A-T cells may bypass the requirement
for ATM in restoring some phenotypes of A-T cells.
To test this hypothesis, we used two different dominant-negative
mutants, Pin2-(1-372) and Pin2-(1-316), to inhibit the function of
endogenous Pin2/TRF1. Pin2/TRF1 functions as a dimer and contains an
N-terminal dimerization domain and a C-terminal telomeric DNA-binding domain (43, 45). Overexpression of the C-terminal truncation Pin2
mutants would act in a dominant-negative manner by forming heterodimers
with the endogenous protein and preventing endogenous Pin2/TRF1 from
performing its normal functions, as shown previously (43, 45). To
facilitate the identification of transfected cells and to monitor
expression of mutant proteins in stable cell lines, we inserted a GFP
epitope tag, which does not affect Pin2/TRF1 function, as shown
previously (39, 51). We transfected A-T22IJE-T (A-T cells) with the
GFP·Pin2 mutants and control GFP and generated multiple independent
cell lines stably expressing GFP·Pin2-(1-316) (A-T-GFP·Pin2-(1-316)), GFP·Pin2-(1-372)
(A-T-GFP·Pin2-(1-372)), or GFP (A-T-GFP) (Fig.
1, A and B). As
controls, ATM and the control vector were also stably transfected into
the same A-T cells, producing A-T-ATM and A-T-V cells, respectively
(Fig. 1C), as described previously (39, 55). A-T cells were
originally derived from primary A-T fibroblasts and immortalized by
SV40 (60), which harbor a homozygous frameshift mutation at codon 762 of the ATM gene and contain no ATM protein because the
truncated protein is not stable, as shown previously (39, 55, 61, 62).
Protein levels of GFP·Pin2 mutants in stable cell lines were similar
to that of control GFP, as determined by immunoblotting analysis with
anti-GFP antibodies (Fig. 1A) and by measuring the intensity of the GFP fluorescence using flow cytometry (Fig. 1B).
Furthermore, without DNA damage, there was no detectable difference
either in the cell cycle profile or the cell morphology between the
control GFP and GFP·Pin2/TRF1 mutant-expressing cells (Figs.
4B, 5B, and 7B). Similarly,
re-expression of ATM in A-T cells did not affect the cell cycle profile
(Figs. 4A, 5A, and 7A). Similar
phenotypes as described below were observed in multiple independent
cell clones isolated from each stable transfection (Fig. 5A,
data not shown). These results indicate that stable expression of
dominant-negative Pin2/TRF1 mutants does not have any general effect on
cell cycle progression, similar to re-expression of ATM.

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 1.
Stable expression of two different
dominant-negative Pin2/TRF1 mutants or ATM in A-T cells.
A and B, expression of GFP·Pin2 mutants.
A-T22IJE-T cells were transfected with control GFP vector (A-T-GFP) or
GFP·Pin2 mutants (A-T-GFP·Pin2-(1-372)) or
A-T-GFP·Pin2-(1-316), and multiple stable cell lines were
established from each transfection. Expression of transgenes was
detected by immunoblotting analysis with anti-GFP antibodies
(A) or by measuring the fluorescence intensity of GFP using
flow cytometry (B). C, re-expression of ATM in
A-T cells. A-T22IJE-T cells were stably transfected with pEBS7 vector
encoding full-length ATM tagged with FLAG (A-T-ATM) or the control
vector (A-T-V), followed by detection of expression of ATM using
immunoblotting analysis with anti-ATM antibodies (top panel)
or with anti-FLAG antibodies (bottom panel). Note,
ATM-positive HeLa cells were used as a control for ATM
expression.
|
|
Dominant-negative Pin2/TRF1 Mutants Elongate
Telomeres in A-T Cells--
Primary A-T fibroblasts and lymphocytes,
as well as transformed A-T fibroblasts and lymphoblasts, have been
found to have unusually short telomeres (26-28). Furthermore,
expression of a dominant-negative ATM fragment in normal cells results
in a decrease in average telomere repeat length (29), whereas
expression of the yeast ATM homologue TEL1 in A-T cells restores
telomere shortening (36). These results indicate that telomere
shortening is one of the characteristic features of A-T cells. Because
expression of a dominant-negative Pin2/TRF1 mutant causes telomere
elongation in other cells (45), we would be interested in examining
whether stable expression of dominant-negative Pin2/TRF1
mutants affects telomere length in A-T cells.
To examine this possibility, we determined telomere length, after about
5 months of subculture from the establishment of stable cell lines,
using two different methods. First, we used fluorescence in
situ hybridization with fluorescent telomere repeats (Telomere FISH) to qualify the intensity of telomere signals in nuclei as described previously (39). As shown in Fig.
2A, the telomeric signal
intensity in both of the mutant-expressing cells was stronger than that
in control GFP-expressing cells. When the fluorescence intensity was
measured in more than 300 cells using the NIH Image software,
quantitative increases were readily found in both GFP·Pin2-(1-372) or GFP·Pin2-(1-316)-expressed A-T cells, as compared with the cells
expressing control GFP cells (Fig. 2B). To confirm these results, we measured telomere restriction fragment length in stable cell lines using genomic Southern analysis as described previously (48). As shown in Fig. 2B, control A-T-GFP cells contained
rather short and relatively uniform telomeres, which is similar to
other A-T cell lines (26-28, 36). However, telomeres in both
A-T-GFP·Pin2-(1-372) and A-T-GFP·Pin2-(1-316) cells were
significantly lengthened and more heterogeneous (Fig. 2C).
Furthermore, there was a good correlation in the telomere signals
determined by telomere FISH and genomic Southern analysis (Fig. 2).
Interestingly, expression of yeast TEL also results in a similar
increase in telomere length in A-T cells (36). Therefore, these results
indicate that both Pin2-(1-372) and Pin2-(1-316) mutants increase
telomere length in A-T cells, confirming that they indeed act as
dominant-negative mutants to inhibit endogenous Pin2/TRF1 function in
A-T cells, as shown previously in other cells (45).

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 2.
Dominant-negative Pin2/TRF1 mutants elongate
telomeres of A-T cells. A and B, detection
of telomere length by telomere FISH. After 5 months of culture, stable
A-T cells were fixed and stained with fluorescent telomeric DNA probe.
A, the samples were observed using a fluorescence
microscope, and digital images were recorded with a CCD camera.
B, quantitative fluorescence intensity of telomeric signals
in individual cells was evaluated by NIH Image software. C,
measurement of telomere restriction fragment length by Southern
analysis. Genomic DNA was isolated from stable A-T cell lines after 5 months of culture and digested with HinfI and
RsaI, followed by Southern blot analysis using a TTAGGG
repeat as a probe.
|
|
Dominant-negative Pin2/TRF1 Mutants Correct the
Radiosensitivity of A-T Cells--
A prominent and characteristic
abnormality associated with ATM mutations is hypersensitivity to
ionizing radiation, which can be observed in A-T patients exposed to
therapeutic levels (63, 64) and in cultured cells from these patients
(65, 66). We have previously demonstrated that following
ionizing radiation, ATM phosphorylates Pin2/TRF1 (39). Furthermore,
ATM-phosphorylation site mutants or dominant-negative mutants partially
reduce the radiosensitivity of A-T cells in transient transfection
(39). Together with the results described below in Fig. 5, these
results suggest that dominant-negative Pin2/TRF1 mutants might be
expected to enhance cell survival in A-T cells post-irradiation.
To examine the effects of the Pin2/TRF1 mutants on the radiosensitivity
of A-T cells, various GFP stable cell lines were treated with ionizing
radiation, followed by monitoring of cell morphology and growth at
various times after the treatment. At 24 h post-irradiation, the
majority of A-T-GFP and A-T-V cells were contracted, rounded up, and
loosely attached to culture flasks (Fig.
3, data not shown). DAPI staining
revealed that nuclei in the cells became condensed and fragmented, with
some cells blocked at anaphase (Fig. 3). Surprisingly, both
A-T-GFP·Pin2-(1-372) and A-T-GFP·Pin2-(1-316) were not contracted
or rounded up, and nuclei were not condensed. Instead, most of these
cells exhibited interphase cell morphologies that were similar to those
of A-T-ATM cells (Fig. 3, data not shown). These results indicate that
the dominant-negative Pin2/TRF1 mutants prevent A-T cells from entering
apoptosis right after ionizing radiation.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 3.
Dominant-negative Pin2/TRF1 mutants
reduce the radiosensitivity of A-T cells. A-T cell lines
stable expressing with control GFP (A-T-GFP), GFP·Pin2-(1-372)
(A-T-GFP·Pin2-(1-372)), or GFP·Pin2-(1-316)
(A-TGFP·Pin2-(1-316)) were treated with 5 grays (Gy) of
-radiation and harvested at 24 h after the treatment, followed
by examination of their morphology under a microscope after staining
with the DNA dye DAPI. Arrows point to a pair of cells
delayed at anaphase, a phenotype often observed in A-T cells after DNA
damage.
|
|
After further culture for 3-4 days post-irradiation, a small fraction
of A-T-GFP and A-T-V cells that did not round up eventually exhibited
increased size and a flattened morphology (Fig.
4, A and B).
Furthermore, they were also stained positively for SA- -Gal (Fig. 4,
A and B), a biomarker for identifying senescent
human cells in culture and in aging skin in vivo (56). These
cells failed to proliferate, and almost no cell colonies were observed after 2-3 weeks of further culture (Fig. 4C). Because the
parental A-T cell line AT22IJE-T was immortalized by SV40 to escape
premature senescence (60), these data suggest that DNA damage induces immortalized A-T cells to enter premature senescence. More importantly, under the same conditions, senescent phenotypes, including the morphological changes and positive SA- -Gal staining, were rarely found in A-T-GFP·Pin2-(1-372) or A-T-ATM cell lines at 3-4 day post-irradiation (Fig. 4, A and B), indicating
that these cells are refractory to premature senescence after DNA
damage. Moreover, these cells continued to divide and eventually formed
many cell colonies after 2-3 week of further culture (Fig.
4C). Similar results were also observed with
A-T-GFP·Pin2-(1-316) (data not shown). These results on both short
term and long term cell survival consistently indicate that expression
of either of the dominant-negative Pin2/TRF1 mutants corrects the
radiosensitivity of A-T cells, with potency similar to that of
re-expression of ATM.

View larger version (59K):
[in this window]
[in a new window]
|
Fig. 4.
Dominant-negative Pin2/TRF1 mutants restore
the ability of A-T cells to proliferate after ionizing radiation.
A-T cell lines stable expressing with ATM or control vector
(A and C) or GFP·Pin2 mutant or control GFP
(B and C) were treated with -radiation. At 3 days after -radiation, cells were stained with X-gal staining to
detect senescence-associated -galactosidase activity (A
and B). At 2-3 weeks after -radiation days, cells were
stained with crystal violet to count the number of cell colonies
(C). Similar results to those of A-T-GFP·Pin2-(1-372)
were also obtained with A-T cells expressing GFP·Pin2-(1-316) (data
not shown).
|
|
Dominant-negative Pin2/TRF1 Mutants Restore the
G2/M Checkpoint in A-T Cells--
It has been reported
that radiosensitive fibroblasts from A-T patients exhibit less mitotic
delay than cells from normal donors when exposed to irradiation (59).
These findings have been confirmed using lymphoblastoid cells
synchronized at G2/M, demonstrating that the G2
checkpoint is not activated in A-T cells shortly after irradiation
(25). This failure to delay in G2 leads to premature entry
into mitosis and then apoptosis (25), which is believed to be the major
reason for the hypersensitivity of A-T cells to ionizing radiation.
Indeed, expression of yeast Chk1 or Tel1 reduces radiosensitivity as
well as the G2/M checkpoint defect (36, 67). Given that the
dominant-negative Pin2/TRF1 mutants correct the radiosensitivity of A-T
cells, rendering them resistant to apoptosis after ionizing radiation,
they may also restore the G2/M checkpoint defect in A-T cells.
To examine this possibility, we determined the cell cycle status of
these cells using flow cytometry analysis. As shown previously (25, 36,
67), following ionizing radiation both A-T-V and A-T-GFP cells failed
to delay entry into mitosis, as indicated by the lack of accumulation
of cells with the 4N DNA content (Fig. 5). Instead, these cells entered abortive
mitosis and apoptosis, as indicated by the appearance of cells
containing the sub-G1 DNA content (Fig. 5), a
characteristic feature of apoptosis. This is consistent with apoptotic
cell morphology (Fig. 3). In contrast, A-T-ATM cells were delayed entry
into mitosis because of accumulation of the 4N DNA content (Fig.
5A). These results indicate that GFP has no significant
effect on the G2/M checkpoint and confirm that ATM restores
the G2/M checkpoint defect in A-T cells, as shown previously (25, 36, 67). Importantly, under the same conditions, both
A-T-GFP·Pin2-(1-372) and A-T-GFP·Pin2-(1-316) were accumulated with the 4N DNA content after ionizing radiation (Fig. 5B).
Because these cells contained the interphase nuclear morphology (Fig. 4), they were not blocked in mitosis but rather in G2, a
phenotype similar to that resulting from re-expression of ATM (Fig.
5A). These results indicate that, as with re-expression of
ATM, inhibition of Pin2/TRF1 can specifically restore the
G2/M checkpoint defect in A-T cells in response to DNA
damage.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 5.
Dominant-negative Pin2/TRF1 mutants restore
the G2/M checkpoint defect in A-T cells. A-T cell
lines that were stably transfected with control vector (A-T-V1) or ATM
(A-T-A5.1 or-A5.10) (A) or with control GFP vector (A-T-GFP)
or two different GFP·Pin2 mutants (A-T-GFP·Pin2-(1-372) or
-Pin2-(1-316)) (B) were treated with -radiation. 24 h later, cells were stained with propidium iodide, followed by flow
cytometry to determine the cell cycle profile. Percentages and
arrows indicate apoptotic cells with the sub-G1
DNA content in total cells examined.
|
|
Dominant-negative Pin2/TRF1 Mutants Do Not Affect
Cdc2 Activation after DNA Damage--
After demonstrating that
inhibition of Pin2/TRF1 function corrects the defective
G2/M checkpoint in A-T cells, we were interested whether it
could prevent activation of Cdc2. Following ionizing DNA damage, ATM
regulates several Cdc2 upstream regulators to ensure that cyclin B/Cdc2
is not activated as would be indicated by an increase in the
phosphorylation of Cdc2 on Tyr-15 and a decrease in the Cdc2 H1 kinase
activity following DNA damage. However, in A-T cells, cyclin B/Cdc2
cannot be kept in an inactive state after DNA damage, as suggested by
no increase in phosphorylation of Cdc2 on Tyr-15 and no decrease in the
Cdc2 H1 kinase activity (68, 69).
To examine whether inhibition of Pin2/TRF1 function affects Cdc2
activation, we subjected stable A-T cell lines to ionizing radiation
and then assayed Cdc2 Tyr phosphorylation and its histone H1 kinase
activity. As shown previously (68, 69), following ionizing radiation
both Cdc2 Tyr phosphorylation and its histone H1 kinase activity
remained unchanged in A-T-V1 cells, whereas in A-T-ATM5.1 cells, Tyr
phosphorylation of Cdc2 increased, and its kinase activity was
inhibited (Fig. 6A). Under the
same conditions, both Cdc2 Tyr phosphorylation and its histone H1
kinase activity remained unchanged in A-T cell lines stably expressing
either GFP, GFP·Pin2-(1-372), or GFP·Pin2-(1-316) (Fig.
6B), although they were arrested in G2 after
ionizing radiation (Figs. 3 and 5B), like A-T-ATM5.1 cells
(Fig. 5A). These results indicate that inhibition of
Pin2/TRF1 appears not to inhibit activation of Cdc2 in A-T cells even
though they were arrested in G2 after ionizing radiation.
This is consistent with the notion that ATM directly regulates the
function of Pin2/TRF1 by binding and phosphorylating Pin2/TRF1, as
proposed earlier (39).

View larger version (74K):
[in this window]
[in a new window]
|
Fig. 6.
Dominant-negative Pin2/ TRF1 mutants
do not inhibit Cdc2 activation after ionizing radiation in A-T
cells. The stable A-T cell lines were treated with -radiation
as described in Fig. 5, followed by the harvesting of cells at 24 h after treatment. The Tyr-15 phosphorylation status of Cdc2 was
determined by subjecting cell lysates to immunoblotting analysis
with phosphorylated Tyr-15-specific antibodies (upper
panels). The Cdc2 kinase activity was determined by subjecting
cell lysates to immunoprecipitation with anti-cyclin B1 antibodies,
followed by a kinase assay using histone H1 as a substrate (lower
panels). Please note, the amounts of Cdc2 immunoprecipitated and
H1 added were similar in all samples, as determined by Cdc2 immunoblot
and Coomassie Blue staining on the same immunoblotting membranes,
respectively.
|
|
Dominant-negative Pin2/TRF1 Mutants Do Not Restore the S Phase
Checkpoint in A-T Cells--
Given that inhibition of Pin2/TRF1
corrects the G2/M checkpoint in A-T cells, we were
interested in the specificity of this rescuing effect. To address this
question, we examined whether the Pin2/TRF1 mutant could also influence
the S phase checkpoint. Exposure of mammalian cells to ionizing
radiation causes inhibition of both initiation of DNA replication and
chain elongation (70). This characteristic pattern of inhibition of DNA
synthesis is very much reduced in A-T cells, and the phenomenon has
been referred to as radioresistant DNA synthesis (70, 71). Expression
of yeast Chk1 or Tel1 in A-T cells restores the G2/M but
not the S phase checkpoint defect (36, 67), confirming that different pathways control these two checkpoints. Because endogenous Pin2/TRF1 protein is cell cycle regulated, with a low level during G1
and S (43), we suspected that dominant-negative Pin2/TRF1 mutants might
not have significant effects on the S phase checkpoint in A-T cells.
To examine this possibility, we subjected the stable cell lines to
ionizing radiation, pulsed them with BrdUrd for 60 min, and followed by
measuring the incorporation of BrdUrd into DNA using immunostaining and
then flow cytometry. As reported previously in A-T cells (70, 71),
A-T-V1 cells continued to synthesize their DNA (Fig.
7A). In contrast, A-T-ATM5.1
cells displayed a normal response to DNA damage, reducing the DNA
synthesis approximately 3-fold after ionizing radiation (Fig.
7A), consistent with previous studies (36, 67, 70, 71).
Importantly, GFP-, GFP·Pin2-(1-372)-, or
GFP·Pin2-(1-316)-expressing cells continued to synthesize DNA following ionizing radiation (Fig. 7B), with the percentage
of BrdUrd-positive cells being similar to that of A-T-V1 cells (Fig. 7). These results indicate that the dominant-negative Pin2/TRF1 mutants
do not restore the S phase checkpoint defect in A-T cells, demonstrating that the ability of Pin2/TRF1 inhibition to restore the
G2/M checkpoint in A-T cells is highly specific.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 7.
Dominant-negative Pin2/TRF1 mutants do not
restore the S phase checkpoint in A-T cells. The stable A-T cell
lines were treated with -radiation as described in Fig. 5. 24 h
later, cells were incubated with BrdUrd for 60 min, and incorporation
of BrdUrd into cells was determined by staining cells with
FITC-conjugated antiBrdUrd monoclonal antibody, followed by flow
cytometry. Percentages indicate the fraction of BrdUrd-positive cells
in total cells examined.
|
|
 |
DISCUSSION |
To examine the importance of Pin2/TRF1 in mediating
ATM-dependent regulation, we here stably expressed two
different dominant-negative Pin2/TRF1 mutants to inhibit the function
of endogenous Pin2/TRF1 in A-T cells. Both Pin2/TRF1 mutants increased
telomere length in A-T cells. Surprisingly, both mutants reduced
radiosensitivity and restored the G2/M checkpoint defect in
A-T cells. These rescuing effects are highly specific because neither
of them corrected the S phase checkpoint defect in the same cells.
These results indicate that inhibition of Pin2/TRF1 in A-T cells is
able to bypass the requirement for ATM in specifically suppressing
telomere shortening, radiosensitivity, and the G2/M
checkpoint defect. Given our previous findings that following DNA
damage ATM phosphorylates Pin2/TRF1 and suppresses its ability to
induce abortive mitosis and apoptosis, these results indicate that
Pin2/TRF1 plays a critical role in ATM-dependent regulation
of telomeres and mitotic regulation.
Whereas the length of telomeres decreases with each cell division in
primary cells, the average telomere length of immortalized, telomerase-positive cells is generally stable during long term culture
(72-74). Consistent with these observations, our A-T cells (A-T22IJE-T) contain active telomerase activity, and their mean telomere length is not obviously affected by continuous culturing or by
expression of GFP (Fig. 2, data not shown). Furthermore, they are very
similar to the telomere lengths reported for other A-T cell lines
(26-28, 36). Therefore, telomere length in our A-T cells is stable at
least over the period of our experiments. However, after 5 months of
culturing following transfection, telomere length in A-T cells
expressing dominant-negative Pin2/TRF1 mutant, either
GFP·Pin2-(1-372) or GFP·Pin2-(1-316), but not control GFP, is
significantly increased to almost double those of the parental A-T line
(Fig. 3). Interestingly, a similar increase in telomere length is also
reported by overexpression of yeast TEL1 in A-T cells (36). These
results indicate that both Pin2/TRF1 mutants increase telomere length
in A-T cells. Because Pin2/TRF1 contains only one single Myb-type
telomeric DNA-binding motif at its C terminus, it needs to form dimers
to bind telomeres. Given that both Pin2-(1-372) and Pin2-(1-316)
contain the dimerization domain and form heterodimers with the
full-length protein (43, 75), they likely act in a dominant-negative
fashion to inhibit the ability of endogenous Pin2/TRF1 to bind
telomeres, as shown previously (45). Although Pin2/TRF1 does not
directly inhibit telomerase activity (45), it can directly bind the
potent telomerase inhibitor PinX1 and target it to telomeres (48).
Therefore, it is possible that Pin2/TRF1 inhibits telomere elongation
by telomerase via PinX1. However, further experiments are needed to
determine how Pin2/TRF1 inhibits telomere elongation.
The most significant finding of our study is that inhibition of
Pin2/TRF1 can complement radiosensitivity and the G2/M
checkpoint defect in A-T cells, which can be readily detected by both
short term and long term cell survival assays. Most control
vector-transfected or GFP-expressing A-T cells enter apoptosis
24 h after ionizing radiation (Fig. 3), and a small fraction of
them that do not enter apoptosis at 24 h eventually enter
senescence 3-4 days post-irradiation (Fig. 4). Therefore, almost no
cell colonies are observed 2-3 weeks post-irradiation (Fig. 4). In
sharp contrast, A-T cells stably expressing dominant-negative Pin2/TRF1
mutants do not enter apoptosis right after ionizing radiation (Fig. 3).
Instead, these delay entry into mitosis and are accumulated in
G2 (Figs. 3 and 5), a normal DNA damage response (4, 5, 25,
59). These Pin2/TRF1-inhibited A-T cells do not enter senescence but
continue to divide, eventually leading to the formation of many cell
colonies (Fig. 4). Interestingly, these phenotypes of
Pin2/TRF1-inhibited A-T cells are indistinguishable from those of A-T
cells re-expressing ATM (Figs. 4 and 5). In contrast, inhibition of
Pin2/TRF1 completely fails to correct the S phase checkpoint defect in
the same cells, whereas ATM can restore both the S and G2/M
checkpoint defect in A-T cells (Fig. 7). Similarly, expression of yeast
CHK1 or TEL1 gene in A-T cells complements
radiosensitivity and the G2/M checkpoint defect but not the
S phase checkpoint defect (36, 67). These results indicate that
inhibition of Pin2/TRF1 can specifically complement radiosensitivity
and the G2/M checkpoint defect in A-T cells.
The finding that direct inhibition of endogenous Pin2/TRF1 function can
bypass the requirement for ATM in ATM-negative cells by specifically
rescuing telomere shortening, radiosensitivity, and the
G2/M checkpoint provides convincing evidence for the
functional importance of Pin2/TRF1 in mediating
ATM-dependent regulation. These results strongly argue that
the negative regulation of Pin2/TRF1 by ATM, presumably via
phosphorylation, plays a critical role in maintaining telomeres and
mitotic regulation. The fact that this negative regulatory mechanism is
missing in ATM-negative cells may suggest why these cells contain
shortened telomeres and are hypersensitive to ionizing radiation (1,
26-30, 55). Thus, Pin2/TRF1 is a critical ATM downstream target in the
regulation of telomeres and in mitotic checkpoint regulation.
The notion that Pin2/TRF1 is involved in the ATM-dependent
G2/M, but not S phase, checkpoint is consistent with other
studies linking telomere regulation specifically to mitotic progression (52-54). More importantly, it is consistent with the tightly regulated expression pattern and function of Pin2/TRF1 during the cell cycle. Pin2/TRF1 contains a motif related to the destruction box that mediates
degradation of many mitotic proteins, including cyclin B (43, 76).
Furthermore, the levels of Pin2/TRF1 are strikingly increased at the
G2/M transition, followed by degradation as cells exit from
mitosis. This cell cycle-dependent regulation of Pin2/TRF1 is likely due to regulated protein degradation. Our previous
study indicates that overexpression of Pin2/TRF1 promotes mitotic entry and apoptosis (51). Thus, these results indicate the function of
Pin2/TRF1 is tightly regulated during the cell cycle, reaching its
maximum at the G2/M transition when it exerts its function.
It remains to be determined how Pin2/TRF1 is involved in
ATM-dependent G2/M checkpoint regulation. Upon
double-strand DNA breaks, activation of ATM kinase in normal cells
phosphorylates several downstream target proteins, including p53 and
checkpoint kinases Chks (2, 3). Chks inhibit Cdc25C and activate Wee1, which are the protein phosphatase and kinase that activate and inhibit
Cdc2, respectively. In addition, Chks and ATM also phosphorylate p53,
resulting in an increase in transcription of the Cdk inhibitor p21 and
the Cdc2 sequester 14-3-3 . These multiple and redundant pathways
have been shown to ensure that Cdc2 is not activated, and cells will
delay entry into mitosis following DNA damage. However, because these
G2/M checkpoint cascades are disrupted and Cdc2 cannot be
kept in an inactive state after DNA damage in ATM-negative cells, they
fail to delay entry into mitosis and instead enter abortive mitosis and
apoptosis. Surprisingly, it appears that inhibition of Pin2/TRF1
restores the G2/M checkpoint without inhibiting Cdc2 in A-T
cells after ionizing radiation, at least as assayed by Cdc2 tyrosine
phosphorylation and H1 kinase activity (Fig. 6). These results suggest
that ATM may also regulate the G2/M checkpoint via
controlling the function of Pin2/TRF1. Indeed, ATM regulates the
mitotic function of Pin2/TRF1 via phosphorylation on Ser-219 (39).
These results suggest that Cdc2 and Pin2/TRF1 may be collaboratively or
sequentially involved in the cascade of the G2/M checkpoint
control, although their exact relation remains to be determined.
In summary, we have demonstrated for the first time that inhibition of
Pin2/TRF1 via two different dominant-negative mutants is sufficient to
bypass the requirement for ATM in restoring telomere shortening,
increasing radiosensitivity, and correcting the G2/M checkpoint defect in A-T cells. However, neither of the Pin2/TRF1 mutants restores the S phase checkpoint defect in the same cells, demonstrating the specificity of rescuing effects by inhibition of
Pin2/TRF1. Together with the fact that ATM phosphorylates Pin2/TRF1 and
inhibits its mitotic function, these results provide strong evidence
that Pin2/TRF1 plays an critical role in the ATM-dependent regulation of telomeres and DNA damage response. Further studies on how
Pin2/TRF1 is involved in telomere regulation and DNA damage response
will help understand the physiological and pathological functions of
ATM and elucidate the molecular mechanisms of telomere maintenance and
DNA damage response.
 |
ACKNOWLEDGEMENTS |
We thank Y. Shiloh, R. Abraham, T. Hunter, B. Neel, and L. Cantley for constructive discussions.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants R01GM56230 and R01GM58556 (to K. P. L.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Dept. of Cancer Biology, Dana-Farber Cancer
Inst., and Dept. of Pathology, Harvard Medical School, 1 Jimmy Fund
Way, Boston, MA 02115.
§
A Pew Scholar and Lymphoma and Leukemia Society Scholar. To whom
correspondence should be addressed: Beth Israel Deaconess Medical
Center, HIM 1047, 330 Brookline Ave., Boston, MA 02215. Tel.:
617-667-4143; Fax: 617-667-0610; E-mail:
klu@caregroup.harvard.edu.
Published, JBC Papers in Press, December 13, 2001, DOI10.1074/jbc.M111365200
 |
ABBREVIATIONS |
The abbreviations used are:
ATM, ataxia-telangiectasia-mutated;
A-T, ataxia-telangiectasia cells;
PBS, phosphate-buffered saline;
BrdUrd, deoxybromouridine;
SA- -Gal, senescence-associated -galactosidase;
FITC, fluorescein
isothiocyanate;
GFP, green fluorescent protein;
x-gal, 5-bromo-4-chloro-3-indolyl-b-d-galactopyranoside;
FISH, fluorescent
in situ hybridization;
DAPI, 4',6-diamidino-2-phenylindole.
 |
REFERENCES |
| 1.
|
Savitsky, K.,
Bar, S. A.,
Gilad, S.,
Rotman, G.,
Ziv, Y.,
Vanagaite, L.,
Tagle, D. A.,
Smith, S.,
Uziel, T.,
Sfez, S.,
Ashkenazi, M.,
Pecker, I.,
Frydman, M.,
Harnik, R.,
Patanijali, S. R.,
Simmons, A.,
Clines, G. A.,
Sartiel, A.,
Gatti, R. A.,
Chessa, L.,
Sanal, O.,
Lavin, M. F.,
Jasper, N. G. J.,
Taylor, A. M. R.,
Arlett, C. F.,
Miki, T.,
Weissman, S. M.,
Lovett, M.,
Collin, F. C.,
and Shiloh, Y.
(1995)
Science
268,
1749-1753[Abstract/Free Full Text]
|
| 2.
|
Lavin, M. F.,
and Shiloh, Y.
(1997)
Annu. Rev. Immunol.
15,
177-202[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Abraham, R. T.
(2001)
Genes Dev.
15,
2177-2196[Free Full Text]
|
| 4.
|
Leeper, D. B.,
Schneiderman, M. H.,
and Dewey, W. C.
(1972)
Radiat. Res.
50,
401-417[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Konig, K.,
and Baisch, H.
(1980)
Radiat. Environ. Biophys.
18,
257-266[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Weinert, T. A.,
and Hartwell, L. H.
(1990)
Mol. Cell. Biol.
10,
6554-6564[Abstract/Free Full Text]
|
| 7.
|
Li, R.,
and Murray, A. W.
(1991)
Cell
66,
519-531[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Hartwell, L. H.,
and Kastan, M. B.
(1994)
Science
266,
1821-1828[Abstract/Free Full Text]
|
| 9.
|
Shafman, T.,
Khanna, K. K.,
Kedar, P.,
Spring, K.,
Kozlov, S.,
Yen, T.,
Hobson, K.,
Gatei, M.,
Zhang, N.,
Watters, D.,
Egerton, M.,
Shiloh, Y.,
Kharbanda, S.,
Kufe, D.,
and Lavin, M. F.
(1997)
Nature
387,
520-523[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Baskaran, R.,
Wood, L. D.,
Whitaker, L. L.,
Canman, C. E.,
Morgan, S. E., Xu, Y.,
Barlow, C.,
Baltimore, D.,
Wynshaw-Boris, A.,
Kastan, M. B.,
and Wang, J. Y.
(1997)
Nature
387,
516-519[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Banin, S.,
Moyal, L.,
Shieh, S.,
Taya, Y.,
Anderson, C. W.,
Chessa, L.,
Smorodinsky, N. I.,
Prives, C.,
Reiss, Y.,
Shiloh, Y.,
and Ziv, Y.
(1998)
Science
281,
1674-1677[Abstract/Free Full Text]
|
| 12.
|
Canman, C. E.,
Lim, D. S.,
Cimprich, K. A.,
Taya, Y.,
Tamai, K.,
Sakaguchi, K.,
Appella, E.,
Kastan, M. B.,
and Siliciano, J. D.
(1998)
Science
281,
1677-1679[Abstract/Free Full Text]
|
| 13.
|
Sarkaria, J. N.,
Tibbetts, R. S.,
Busby, E. C.,
Kennedy, A. P.,
Hill, D. E.,
and Abraham, R. T.
(1998)
Cancer Res.
58,
4375-4382[Abstract/Free Full Text]
|
| 14.
|
Khanna, K. K.,
Keating, K. E.,
Kozlov, S.,
Scott, S.,
Gatei, M.,
Hobson, K.,
Taya, Y.,
Gabrielli, B.,
Chan, D.,
Lees-Miller, S. P.,
and Lavin, M. F.
(1998)
Nat. Genet.
20,
398-400[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Matsuoka, S.,
Huang, M.,
and Elledge, S. J.
(1998)
Science
282,
1893-1897[Abstract/Free Full Text]
|
| 16.
|
Cortez, D.,
Wang, Y.,
Qin, J.,
and Elledge, S. J.
(1999)
Science
286,
1162-1166[Abstract/Free Full Text]
|
| 17.
|
Kim, S. T.,
Lim, D. S.,
Canman, C. E.,
and Kastan, M. B.
(1999)
J. Biol. Chem.
274,
37538-37543[Abstract/Free Full Text]
|
| 18.
|
Wu, X.,
Ranganathan, V.,
Weisman, D. S.,
Heine, W. F.,
Ciccone, D. N.,
O'Neill, T. B.,
Crick, K. E.,
Pierce, K. A.,
Lane, W. S.,
Rathbun, G.,
Livingston, D. M.,
and Weaver, D. T.
(2000)
Nature
405,
477-482[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Zhao, S.,
Weng, Y. C.,
Yuan, S. S.,
Lin, Y. T.,
Hsu, H. C.,
Lin, S. C.,
Gerbino, E.,
Song, M. H.,
Zdzienicka, M. Z.,
Gatti, R. A.,
Shay, J. W.,
Ziv, Y.,
Shiloh, Y.,
and Lee, E. Y.
(2000)
Nature
405,
473-477[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Barlow, C.,
Hirotsune, S.,
Paylor, R.,
Liyanage, M.,
Eckhaus, M.,
Collins, F.,
Shiloh, Y.,
Crawley, J. N.,
Ried, T.,
Tagle, D.,
and Wynshaw, B. A.
(1996)
Cell
86,
159-171[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Xu, Y.,
Ashley, T.,
Brainerd, E. E.,
Bronson, R. T.,
Meyn, M. S.,
and Baltimore, D.
(1996)
Gene Dev.
10,
2411-2422[Abstract/Free Full Text]
|
| 22.
|
Xu, Y.,
and Baltimore, D.
(1996)
Gene Dev.
10,
2401-2410[Abstract/Free Full Text]
|
| 23.
|
Elson, A.,
Wang, Y.,
Daugherty, C. J.,
Morton, C. C.,
Zhou, F.,
Campos-Torres, J.,
and Leder, P.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
13084-13089[Abstract/Free Full Text]
|
| 24.
|
Rudolph, N. S.,
and Latt, S. A.
(1989)
Mutat. Res.
211,
31-41[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
| Beamish, H., Khanna, K. K., and Lavin, M. F. (1994)
Radiat. Res. S130-133
|
| 26.
|
Pandita, T. K.,
Pathak, S.,
and Geard, C. R.
(1995)
Cytogenet. Cell Genet.
71,
86-93[Medline]
[Order article via Infotrieve]
|
| 27.
|
Xia, S. J.,
Shammas, M. A.,
and Shmookler, R. J.
(1996)
Mutat. Res.
364,
1-11[Medline]
[Order article via Infotrieve]
|
| 28.
|
Metcalfe, J. A.,
Parkhill, J.,
Campbell, L.,
Stacey, M.,
Biggs, P.,
Byrd, P. J.,
and Taylor, A. M.
(1996)
Nat. Genet.
13,
350-353[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Smilenov, L. B.,
Morgan, S. E.,
Mellado, W.,
Sawant, S. G.,
Kastan, M. B.,
and Pandita, T. K.
(1997)
Oncogene
15,
2659-2665[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Morgan, S. E.,
Lovly, C.,
Pandita, T. K.,
Shiloh, Y.,
and Kastan, M. B.
(1997)
Mol. Cell. Biol.
17,
2020-2029[Abstract]
|
| 31.
|
Smilenov, L. B.,
Dhar, S.,
and Pandita, T. K.
(1999)
Mol. Cell. Biol.
19,
6963-6971[Abstract/Free Full Text]
|
| 32.
|
Lustig, A. J.,
and Petes, T. D.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
1398-1402[Abstract/Free Full Text]
|
| 33.
|
Weinert, T. A.,
Kiser, G. L.,
and Hartwell, L. H.
(1994)
Genes Dev.
8,
652-665[Abstract/Free Full Text]
|
| 34.
|
Greenwell, P. W.,
Kronmal, S. L.,
Porter, S. E.,
Gassenhuber, J.,
Obermaier, B.,
and Petes, T. D.
(1995)
Cell
82,
823-829[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Ritchie, K. B.,
Mallory, J. C.,
and Petes, T. D.
(1999)
Mol. Cell. Biol.
19,
6065-6075[Abstract/Free Full Text]
|
| 36.
|
Fritz, E.,
Friedl, A. A.,
Zwacka, R. M.,
Eckardt-Schupp, F.,
and Meyn, M. S.
(2000)
Mol. Biol. Cell
11,
2605-2616[Abstract/Free Full Text]
|
| 37.
|
Wood, L. D.,
Halvorsen, T. L.,
Dhar, S.,
Baur, J. A.,
Pandita, R. K.,
Wright, W. E.,
Hande, M. P.,
Calaf, G.,
Hei, T. K.,
Levine, F.,
Shay, J. W.,
Wang, J. J.,
and Pandita, T. K.
(2001)
Oncogene
20,
278-288[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Chan, S. W.,
Chang, J.,
Prescott, J.,
and Blackburn, E. H.
(2001)
Curr. Biol.
11,
1240-1250[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Kishi, S.,
Zhou, X. Z.,
Nakamura, N.,
Ziv, Y.,
Khoo, C.,
Hill, D. E.,
Shiloh, Y.,
and Lu, K. P.
(2001)
J. Biol. Chem.
276,
29282-29291[Abstract/Free Full Text]
|
| 40.
|
Chong, L.,
van Steensel, B.,
Broccoli, D.,
Erdjument, B. H.,
Hanish, J.,
Tempst, P.,
and de Lange, T.
(1995)
Science
270,
1663-1667[Abstract/Free Full Text]
|
| 41.
|
Lu, K. P.,
Hanes, S. D.,
and Hunter, T.
(1996)
Nature
380,
544-547[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Lu, K. P.
(2000)
Prog. Cell Cycle Res.
4,
83-96[Medline]
[Order article via Infotrieve]
|
| 43.
|
Shen, M.,
Haggblom, C.,
Vogt, M.,
Hunter, T.,
and Lu, K. P.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
13618-13623[Abstract/Free Full Text]
|
| 44.
|
Young, A. C.,
Chavez, M.,
Giambernardi, T. A.,
Mattern, V.,
McGill, J. R.,
Harris, J. M.,
Sarosdy, M. F.,
Patel, P.,
and Sakaguchi, A. Y.
(1997)
Somat. Cell Mol. Genet.
23,
275-286[Medline]
[Order article via Infotrieve]
|
| 45.
|
van Steensel, B.,
and de Lange, T.
(1997)
Nature
385,
740-743[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Smith, S.,
Giriat, I.,
Schmitt, A.,
and de Lange, T.
(1998)
Science
282,
1484-1487[Abstract/Free Full Text]
|
| 47.
|
Kim, S. H.,
Kaminker, P.,
and Campisi, J.
(1999)
Nat. Genet.
23,
405-412[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Zhou, X. Z.,
and Lu, K. P.
(2001)
Cell
107,
347-359[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Nakamura, M.,
Zhou, X. Z.,
and Lu, K. P.
(2001)
Curr. Biol.
11,
1062-1067[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Nakamura, M.,
Zhou, X. Z.,
Kishi, S.,
Kosugi, I.,
Tsutsui, Y.,
and Lu, K. P.
(2001)
Curr. Biol.
11,
1512-1516[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Kishi, S.,
Wulf, G.,
Nakamura, M.,
and Lu, K. P.
(2001)
Oncogene
20,
1497-1508[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Sandell, L. L.,
and Zakian, V. A.
(1993)
Cell
75,
729-739[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Ahmad, K.,
and Golic, K. G.
(1999)
Genetics
151,
1041-1051[Abstract/Free Full Text]
|
| 54.
|
Kirk, K. E.,
Harmon, B. P.,
Reichardt, I. K.,
Sedat, J. W.,
and Blackburn, E. H.
(1997)
Science
275,
1478-1481[Abstract/Free Full Text]
|
| 55.
|
Ziv, Y.,
Bar-Shira, A.,
Pecker, I.,
Russell, P.,
Jorgensen, T. J.,
Tsarfati, I.,
and Shiloh, Y.
(1997)
Oncogene
15,
159-167[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Dimri, G. P.,
Lee, X.,
Basile, G.,
Acosta, M.,
Scott, G.,
Roskelley, C.,
Medrano, E. E.,
Linskens, M.,
Rubelj, I.,
Pereira-Smith, O.,
et al..
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
9363-9367[Abstract/Free Full Text]
|
| 57.
|
Ziv, Y.,
Bar-Shira, A.,
Jorgensen, T. J.,
Russell, P. S.,
Sartiel, A.,
Shows, T. B.,
Eddy, R. L.,
Buchwald, M.,
Legerski, R.,
Schimke, R. T.,
et al..
(1995)
Somatatic Cell Mol. Genet.
21,
99-111
|
| 58.
|
Lu, K. P.,
and Hunter, T.
(1995)
Cell
81,
413-424[CrossRef][Medline]
[Order article via Infotrieve]
|
| 59.
|
Zampetti-Bosseler, F.,
and Scott, D.
(1981)
Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med.
39,
547-558[Medline]
[Order article via Infotrieve]
|
| 60.
|
Ziv, Y.,
Jaspers, N. G.,
Etkin, S.,
Danieli, T.,
Trakhtenbrot, L.,
Amiel, A.,
Ravia, Y.,
and Shiloh, Y.
(1989)
Cancer Res.
49,
2495-2501[Abstract/Free Full Text]
|
| 61.
|
Gilad, S.,
Khosravi, R.,
Shkedy, D.,
Uziel, T.,
Ziv, Y.,
Savitsky, K.,
Rotman, G.,
Smith, S.,
Chessa, L.,
Jorgensen, T. J.,
Harnik, R.,
Frydman, M.,
Sanal, O.,
Portnoi, S.,
Goldwicz, Z.,
Jaspers, N. G.,
Gatti, R. A.,
Lenoir, G.,
Lavin, M. F.,
Tatsumi, K.,
Wegner, R. D.,
Shiloh, Y.,
and Bar-Shira, A.
(1996)
Hum. Mol. Genet.
5,
433-439[Abstract/Free Full Text]
|
| 62.
|
Lakin, N. D.,
Weber, P.,
Stankovic, T.,
Rottinghaus, S. T.,
Taylor, A. M.,
and Jackson, S. P.
(1996)
Oncogene
13,
2707-2716[Medline]
[Order article via Infotrieve]
|
| 63.
|
Gotoff, S. P.,
Amirmokri, E.,
and Liebner, E. J.
(1967)
Am. J. Dis. Child.
114,
617-625[Abstract/Free Full Text]
|
| 64.
|
Morgan, J. L.,
Holcomb, T. M.,
and Morrissey, R. W.
(1968)
Am. J. Dis. Child.
116,
557-558[Abstract/Free Full Text]
|
| 65.
|
Taylor, A. M.,
Harnden, D. G.,
Arlett, C. F.,
Harcourt, S. A.,
Lehmann, A. R.,
Stevens, S.,
and Bridges, B. A.
(1975)
Nature
258,
427-429[CrossRef][Medline]
[Order article via Infotrieve]
|
| 66.
|
Chen, P. C.,
Lavin, M. F.,
Kidson, C.,
and Moss, D.
(1978)
Nature
274,
484-486[CrossRef][Medline]
[Order article via Infotrieve]
|
| 67.
|
Chen, P.,
Gatei, M.,
O'Connell, M. J.,
Khanna, K. K.,
Bugg, S. J.,
Hogg, A.,
Scott, S. P.,
Hobson, K.,
and Lavin, M. F.
(1999)
Oncogene
18,
249-256[CrossRef][Medline]
[Order article via Infotrieve]
|
| 68.
|
Paules, R. S.,
Levedakou, E. N.,
Wilson, S. J.,
Innes, C. L.,
Rhodes, N.,
Tlsty, T. D.,
Galloway, D. A.,
Donehower, L. A.,
Tainsky, M. A.,
and Kaufmann, W. K.
(1995)
Cancer Res.
55,
1763-1773[Abstract/Free Full Text]
|
| 69.
|
Beamish, H.,
Williams, R.,
Chen, P.,
and Lavin, M. F.
(1996)
J. Biol. Chem.
271,
20486-20493[Abstract/Free Full Text]
|
| 70.
|
Painter, R. B.,
and Young, B. R.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
7315-7317[Abstract/Free Full Text]
|
| 71.
|
Houldsworth, J.,
and Lavin, M. F.
(1980)
Nucleic Acids Res.
8,
3709-3720[Abstract/Free Full Text]
|
| 72.
|
Counter, C. M.,
Avilion, A. A.,
LeFeuvre, C. E.,
Stewart, N. G.,
Greider, C. W.,
Harley, C. B.,
and Bacchetti, S.
(1992)
EMBO J.
11,
1921-1929[Medline]
[Order article via Infotrieve]
|
| 73.
|
Counter, C. M.,
Hirte, H. W.,
Bacchetti, S.,
and Harley, C. B.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
2900-2904[Abstract/Free Full Text]
|
| 74.
|
Klingelhutz, A. J.,
Barber, S. A.,
Smith, P. P.,
Dyer, K.,
and McDougall, J. K.
(1994)
Mol. Cell. Biol.
14,
961-969[Abstract/Free Full Text]
|
| 75.
|
Bianchi, A.,
Smith, S.,
Chong, L.,
Elias, P.,
and de Lange, T.
(1997)
EMBO J.
16,
1785-1794[CrossRef][Medline]
[Order article via Infotrieve]
|
| 76.
|
King, R. W.,
Deshaies, R. J.,
Peters, J. M.,
and Kirschner, M. W.
(1996)
Science
274,
1652-1659[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Cooley, K. M. Baird, V. Faure, T. Wenner, J. L. Stewart, S. Modino, P. Slijepcevic, C. J. Farr, and C. G. Morrison
Trf1 Is Not Required for Proliferation or Functional Telomere Maintenance in Chicken DT40 Cells
Mol. Biol. Cell,
May 15, 2009;
20(10):
2563 - 2571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Kim, M. R. Kang, H. W. Nam, Y.-S. Bae, Y. S. Kim, and I. K. Chung
Regulation of Telomeric Repeat Binding Factor 1 Binding to Telomeres by Casein Kinase 2-mediated Phosphorylation
J. Biol. Chem.,
May 16, 2008;
283(20):
14144 - 14152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Vespa, R. T. Warrington, P. Mokros, J. Siroky, and D. E. Shippen
ATM regulates the length of individual telomere tracts in Arabidopsis
PNAS,
November 13, 2007;
104(46):
18145 - 18150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Lee, K. Perrem, J. W. Harper, K. P. Lu, and X. Z. Zhou
The F-box Protein FBX4 Targets PIN2/TRF1 for Ubiquitin-mediated Degradation and Regulates Telomere Maintenance
J. Biol. Chem.,
January 13, 2006;
281(2):
759 - 768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ohki and F. Ishikawa
Telomere-bound TRF1 and TRF2 stall the replication fork at telomeric repeats
Nucleic Acids Res.,
March 8, 2004;
32(5):
1627 - 1637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Caporossi, G. Argentin, M. Pittaluga, P. Parisi, B. Tedeschi, P. Vernole, and R. Cicchetti
Individual susceptibility to DNA telomerase inhibitors: a study on the chromosome instability induced by 3'-azido-3'-deoxythymidine in lymphocytes of elderly twins
Mutagenesis,
March 1, 2004;
19(2):
99 - 104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Karlseder, L. Kachatrian, H. Takai, K. Mercer, S. Hingorani, T. Jacks, and T. de Lange
Targeted Deletion Reveals an Essential Function for the Telomere Length Regulator Trf1
Mol. Cell. Biol.,
September 15, 2003;
23(18):
6533 - 6541.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Wulf, Y.-C. Liou, A. Ryo, S. W. Lee, and K. P. Lu
Role of Pin1 in the Regulation of p53 Stability and p21 Transactivation, and Cell Cycle Checkpoints in Response to DNA Damage
J. Biol. Chem.,
December 6, 2002;
277(50):
47976 - 47979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Marcotte and E. Wang
Replicative Senescence Revisited
J. Gerontol. A Biol. Sci. Med. Sci.,
July 1, 2002;
57(7):
B257 - 269.
[Abstract]
[Full Text]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|